TP53 and neoplasm: This mutation in TP53 appeared to be heterozygous in the DNA of the clinical tumor samples and of most PDX’s, but the mutant allele dominated the RNASeq reads in all samples, suggesting the mutant allele specific expression or genome deletion of another copy.